[Other] Efficacy and safety of once-weekly cagrilintide-semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a study

Majoy Post time 1 hour(s) ago | Show all posts |Read mode

This post will be closed automatically in 2026-06-14 09:37

Reward10points

Lancet Diabetes Endocrinol

. 2026 Jun 7:S2213-8587(26)00126-9.
doi: 10.1016/S2213-8587(26)00126-9. Online ahead of print.
Efficacy and safety of once-weekly cagrilintide-semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a studyVanita R Aroda 1, Raffaella Buzzetti 2, Stine-Mathilde Dalskov 3, Akshay B Jain 4, Jonas Hughes Larsen 5, Chantal Mathieu 6, Richard E Pratley 7, Alex Videmark 3, Torquil Watt 3, John B Buse 8

Affiliations expand